Telomerase Activity in Pancreatic Cancer Cells After Etoposide Treatment
Author Information
Author(s): Sato N, Mizumoto K, Kusumoto M, Nishio S, Maehara N, Urashima T, Ogawa T, Tanaka M
Primary Institution: Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Hypothesis
Does etoposide treatment lead to increased telomerase activity in pancreatic cancer cells?
Conclusion
Etoposide treatment increases telomerase activity in pancreatic cancer cells, which may contribute to drug resistance.
Supporting Evidence
- Etoposide treatment resulted in two- to threefold increases in telomerase activity.
- Telomerase activation was observed in multiple pancreatic cancer cell lines.
- There was a negative correlation between telomerase activity and the percentage of dead cells after treatment.
Takeaway
When pancreatic cancer cells are treated with a drug called etoposide, they become better at avoiding death, and this is linked to an increase in a special enzyme called telomerase.
Methodology
MIA PaCa-2 cells were treated with etoposide at various concentrations, and telomerase activity was measured.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website